Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alin, Tarlea"'
Autor:
Alin Tarlea, Alexandru A, Georgeta Vremes, Mircea Dediu, D Median, C Gal, Maria Radut, Emilia Crisan
Publikováno v:
Lung Cancer. 63:271-276
For lung cancer, the TNM staging system included atelectasis (At) as a negative prognostic factor, within the T category. However, according to our clinical experience, we observed the opposite. The aim of the study was to evaluate the influence of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68393c55b02f3cb292e488ca5bbf9001
https://doi.org/10.1016/j.lungcan.2008.05.007
https://doi.org/10.1016/j.lungcan.2008.05.007
Autor:
Mircea Dediu, Alexandru A, Teodor Horvat, Rodica Anghel, Constantin Grozavu, Alin Tarlea, Ioan Cordos, Cornel Savu, Polixenia Iorga, Claudiu Nistor, Geanina Miron
Publikováno v:
Lung Cancer. 47:93-101
Summary Background: The impact of adjuvant chemotherapy (CT) in the management of resectable non-small cell lung cancer (NSCLC) is highly debated. The aim of the study was to evaluate the outcome of this category of patients, treated at the Military
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceb4f5a9bd5c0a0e8f52a674aedcb639
https://doi.org/10.1016/j.lungcan.2004.06.008
https://doi.org/10.1016/j.lungcan.2004.06.008
Autor:
Mircea, Dediu, Teodor, Horvat, Alin, Tarlea, Rodica, Anghel, Ioan, Cordos, Geanina, Miron, Polixenia, Iorga, Aurelia, Alexandru, Claudiu, Nistor, Constantin, Grozavu, Cornel, Savu
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 47(1)
The impact of adjuvant chemotherapy (CT) in the management of resectable non-small cell lung cancer (NSCLC) is highly debated. The aim of the study was to evaluate the outcome of this category of patients, treated at the Military Hospital Bucharest (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccd6731dab187b5293f5fd2455536a8c
https://pubmed.ncbi.nlm.nih.gov/15603859
https://pubmed.ncbi.nlm.nih.gov/15603859
Publikováno v:
Annals of Oncology. 23:iv34
Introduction Esophageal cancer is treatable disease, but rarely curable because advanced stages at diagnostic time. The incidence of esophageal cancer has risen in recent decades. In Romania esophageal cancer incidence rate is 1.78%ooo and the mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaadf8fffcd3e0dbf4fe8e13121a915d
https://doi.org/10.1016/s0923-7534(20)30049-1
https://doi.org/10.1016/s0923-7534(20)30049-1
Autor:
Mircea Dediu, Claudiu Nistor, Cornel Savu, Iorga P, Teodor Horvat, Rodica Anghel, Alexandru A, Alin Tarlea, C. Grozavu
Publikováno v:
Lung Cancer. 49:S93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a9ffc32cb01a906be08a34e464970f0
https://doi.org/10.1016/s0169-5002(05)80422-2
https://doi.org/10.1016/s0169-5002(05)80422-2
Publikováno v:
Lung Cancer. 29:113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d04f3656fb07bb0a0f98cfd20babae2
https://doi.org/10.1016/s0169-5002(00)80374-8
https://doi.org/10.1016/s0169-5002(00)80374-8